184 related articles for article (PubMed ID: 35120430)
21. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
22. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
23. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
24. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Yeo Y; Johnson R; Heng C
Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
[TBL] [Abstract][Full Text] [Related]
25. Increasing overdose deaths among Black Americans: a review of the literature.
Gibbons JB; Harris SJ; Solomon KT; Sugarman O; Hardy C; Saloner B
Lancet Psychiatry; 2023 Sep; 10(9):719-726. PubMed ID: 37236218
[TBL] [Abstract][Full Text] [Related]
26. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
[TBL] [Abstract][Full Text] [Related]
27. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
Brothers S; Viera A; Heimer R
J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
[TBL] [Abstract][Full Text] [Related]
28. Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA.
Lui B; White RS; Aaronson J; Hoyler M
J Comp Eff Res; 2022 Jun; 11(9):643-648. PubMed ID: 35521648
[No Abstract] [Full Text] [Related]
29. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
30. Regional Variation in Opioid-Related Emergency Medical Services Transfers During the COVID-19 Pandemic: An Interrupted Time Series Analysis.
Yazdanfard S; Thornton D; Bhatt P; Fatima B; Khalid J; Song J; Varisco TJ
Subst Use Addctn J; 2024 Jan; 45(1):74-80. PubMed ID: 38258862
[TBL] [Abstract][Full Text] [Related]
31. Interrupted time series analysis of drug overdose fatalities in service-related industries versus non-service-related industries during the COVID-19 pandemic, 2018-2021.
Bunn TL; Costich JF; Mirzaian M; Daniels LK; Wang D; Quesinberry D
Inj Prev; 2023 Nov; 29(6):511-518. PubMed ID: 37648420
[TBL] [Abstract][Full Text] [Related]
32. Disability-Adjusted Life-Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States.
Chen Q; Griffin PM; Kawasaki SS
Value Health; 2023 Jun; 26(6):796-801. PubMed ID: 36436793
[TBL] [Abstract][Full Text] [Related]
33. Monthly Trends in Drug Overdose Mortality among Youth Aged 15-34 Years in the United States, 2018-2021: Measuring the Impact of the COVID-19 Pandemic.
Lee H; Singh GK
Int J MCH AIDS; 2022; 11(2):e583. PubMed ID: 36506108
[TBL] [Abstract][Full Text] [Related]
34. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
Alcocer JJ
Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
[TBL] [Abstract][Full Text] [Related]
35. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
36. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic.
DiGennaro C; Garcia GP; Stringfellow EJ; Wakeman S; Jalali MS
Int J Drug Policy; 2021 Dec; 98():103392. PubMed ID: 34325184
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 pandemic impact on opioid overdose deaths among racial groups within the United States: an observational cross-sectional study.
Chu R; Sarnala S; Doan T; Cheng T; Chen AW; Jamal A; Kim G; Huang R; Srinivasan M; Palaniappan L; Gross ER
Br J Anaesth; 2024 Jan; 132(1):201-204. PubMed ID: 37977954
[No Abstract] [Full Text] [Related]
38. A rapid assessment of take-home naloxone provision during COVID-19 in Europe.
McDonald R; Eide D; Abel-Ollo K; Barnsdale L; Carter B; Clausen T; Day E; Fonseca F; Holmén E; Horsburgh K; Kelleher M; Kåberg M; Ladenhauf M; McAuley A; Metrebian N; Neale J; Parkin S; Ratcliffe K; Rintoul C; Smith J; Stifanoviciute V; Torrens M; Thiesen H; Strang J
Int J Drug Policy; 2022 Sep; 107():103787. PubMed ID: 35849935
[TBL] [Abstract][Full Text] [Related]
39. The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States.
Ross JA; Malone PK; Levy S
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S81-S85. PubMed ID: 35476024
[TBL] [Abstract][Full Text] [Related]
40. Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.
Glober N; Mohler G; Huynh P; Arkins T; O'Donnell D; Carter J; Ray B
J Urban Health; 2020 Dec; 97(6):802-807. PubMed ID: 33005988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
